These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7198898

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of responses to stimulation of the cardioaccelerator nerves of the cat by N,N-dimethyldopamine and apomorphine.
    Ilhan M, Long JP, Cannon JG.
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):247-54. PubMed ID: 4447407
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ, Arbilla S, Galzin AM, Langer SZ.
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [Abstract] [Full Text] [Related]

  • 6. Effects of some dopamine analogs and haloperidol on response to stimulation of adrenergic nerves using cat atria in vitro.
    Ilhan M, Long JP, Cannon JG.
    Arch Int Pharmacodyn Ther; 1976 Feb; 219(2):193-204. PubMed ID: 1275615
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The ability of pimozide to prevent inhibition by dopamine analogs of cardioaccelerator nerves in cat hearts.
    Ilhan M, Long JP, Cannon JG.
    Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):70-80. PubMed ID: 984973
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX, Hoffmann IS, James MK, Niedzwiecki DM.
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J, Devanand DP, Carey RJ.
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the sympathetic nervous system by dopamine.
    Ilhan M, Long JP.
    Arch Int Pharmacodyn Ther; 1975 Jul; 216(1):4-10. PubMed ID: 1164103
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.
    Janicki P, Lypko A, Szczudlik A, Libich J.
    Pol J Pharmacol Pharm; 1981 Jul; 33(5):499-502. PubMed ID: 6174959
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in the sensitivities of dopamine receptors to chronic treatment with imipramine & haloperidol in rats.
    Pradhan N, Arunasmitha AS.
    Indian J Med Res; 1990 Aug; 92():293-7. PubMed ID: 2228076
    [Abstract] [Full Text] [Related]

  • 18. Vasodilatation produced by apomorphine in the hindleg of the dog.
    Buylaert WA, Willems JL, Bogaert MG.
    J Pharmacol Exp Ther; 1977 Jun; 201(3):738-46. PubMed ID: 864606
    [Abstract] [Full Text] [Related]

  • 19. Centrally mediated protective effects of dopamine agonists on digitalis-induced ventricular arrhythmias.
    Helke CJ, Gillis RA.
    J Pharmacol Exp Ther; 1978 Nov; 207(2):263-70. PubMed ID: 712616
    [No Abstract] [Full Text] [Related]

  • 20. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH, Diamond BI.
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.